CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seigel, G. M.
Right arrow Articles by Notter, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seigel, G. M.
Right arrow Articles by Notter, M. F.

Cell Growth & Differentiation, Vol 4, Issue 1 1-7, Copyright © 1993 by American Association of Cancer Research


ARTICLES

Differentiation of Y79 retinoblastoma cells induced by succinylated concanavalin A

GM Seigel and MF Notter
Department of Neurobiology and Anatomy, University of Rochester Medical Center, New York 14642.

The growth and differentiation potential of Y79 human retinoblastoma cells was assessed in vitro following treatment with the differentiating agent succinylated concanavalin A (SCA). Since SCA treatment induced Y79 cells to display differentiated morphologies in vitro, we sought to determine potential differentiated phenotypes with the use of retinal cell markers. Seventy-two h after SCA treatment, Y79 cells exhibited a decrease in the glial cell marker GFAP and a dramatic and reversible increase in the photoreceptor marker IRBP, while maintaining neuron-specific enolase and PGP 9.5 positivity. These results were indicative of a predominantly neuronal, photoreceptor cell population in response to SCA treatment. In addition, Y79 cell growth inhibition was observed in response to SCA, which could be reversed within 24 h of treatment with the blocking sugar alpha-methyl-D-mannoside. These changes were accompanied by a significant modulation of the N-MYC oncoprotein, as detected by Western blot analysis and immunocytochemistry. Thus, in this system, the status of N-MYC seems to be closely linked to changes in the growth and differentiated state of SCA-treated Y79 retinoblastoma cells.


This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
H. Akiyama, T. Tanaka, H. Doi, H. Kanai, T. Maeno, H. Itakura, T. Iida, Y. Kimura, S. Kishi, and M. Kurabayashi
Visible light exposure induces VEGF gene expression through activation of retinoic acid receptor-{alpha} in retinoblastoma Y79 cells
Am J Physiol Cell Physiol, March 10, 2005; 288(4): C913 - C920.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Gouble, S. Grazide, F. Meggetto, P. Mercier, G. Delsol, and D. Morello
A New Player in Oncogenesis: AUF1/hnRNPD Overexpression Leads to Tumorigenesis in Transgenic Mice
Cancer Res., March 1, 2002; 62(5): 1489 - 1495.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
Z. Yan, X. Deng, M. Chen, Y. Xu, M. Ahram, B. F. Sloane, and E. Friedman
Oncogenic c-Ki-ras but Not Oncogenic c-Ha-ras Up-regulates CEA Expression and Disrupts Basolateral Polarity in Colon Epithelial Cells
J. Biol. Chem., October 31, 1997; 272(44): 27902 - 27907.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1993 by the American Association of Cancer Research.